OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS

OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS

Detaylı Bibliyografya
Asıl Yazarlar:	Sumner-Jones, S, McCormick, D, Coles, R, Pringle, I, McLachlan, G, Collie, D, Vrettou, C, Davies, J, Alton, E, Gill, DR, Hyde, S
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2009

Benzer Materyaller

3-STEP TAQMAN RT-PCR: ULTIMATE MESSENGER RNA DETECTION SENSITIVITY FOR CF GENE THERAPY CLINICAL TRIALS
Yazar:: McCormick, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes.
Yazar:: Davies, L, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
Yazar:: Davies, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
Yazar:: Alton, E, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
Yazar:: Alton, E, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
Yazar:: Davies, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Towards gene therapy for cystic fibrosis: Biodistribution of GL67A/pGM169 DNA and mRNA following aerosol delivery to the mouse lung
Yazar:: Pringle, I, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes.
Yazar:: Davies, L, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Development of highly sensitive TaqMan RT-PCR assays for quantifying vector mRNA in human samples
Yazar:: Sumner-Jones, S, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Quantifying non-viral gene transfer by real-time PCR: a cautionary tale
Yazar:: Coles, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Topical delivery of NF-kb decoy related oligodeoxynucleotides reduces pro-inflammatory cytokine response associated with cationic lipid: pDNA vector delivery to murine lungs
Yazar:: Varathalingam, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
Yazar:: Griesenbach, U, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer.
Yazar:: Griesenbach, U, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
Yazar:: Hyde, S, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
Yazar:: Alton, E, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
Yazar:: Alton, E, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
Yazar:: Gill, DR, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Delivery of genes into the CF airway
Yazar:: Gill, D, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
Yazar:: Pringle, I, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Moving lentiviral-based gene therapy into a first-in-man CF trial
Yazar:: Griesenbach, D, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

CF‐based optimisation for saliency detection
Yazar:: Yuzhen Niu, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
Yazar:: Pringle, I, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Genetic medicines for CF: Hype versus reality
Yazar:: Alton, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Optimizing aerosol gene delivery and expression in the ovine lung.
Yazar:: McLachlan, G, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.
Yazar:: Pringle, I, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

BrdU Pulse Labelling In Vivo to Characterise Cell Proliferation during Regeneration and Repair following Injury to the Airway Wall in Sheep
Yazar:: Yahaya, B., ve diğerleri
Baskı/Yayın Bilgisi: (2013)

BrdU Pulse Labelling In Vivo to Characterise Cell Proliferation during Regeneration and Repair following Injury to the Airway Wall in Sheep
Yazar:: B. Yahaya, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Development of an immunocytochemical assay to detect human CFTR expression following gene therapy
Yazar:: Davidson, H, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Composition of Herpesvirus Ribonucleoprotein Complexes
Yazar:: Eric S. Pringle, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Characterization of transgene expression and pDNA distribution of the suctioned kidney in mice
Yazar:: Natsuko Oyama, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Towards a first-in-human trial with a pseudotyped lentivirus
Yazar:: Alton, EW, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

EXERCISE CAPACITY AND PHYSICAL ACTIVITY IN PATIENTS WITH CF: DATA FROM THE UK CF GENE THERAPY CONSORTIUM (UKCFGTC) 'RUN-IN' STUDY
Yazar:: Saunders, C, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
Yazar:: Alton, E, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
Yazar:: Alton, E, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Gene therapy for respiratory diseases; progress and a changing context
Yazar:: Alton, EWFW, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Hybrid fibrous architectures-mediated gene transfer by pDNA nanoparticles into macrophages
Yazar:: Jana Ghitman, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice
Yazar:: Marie-Lynn Cuypers, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Development of pDNA and Recombinant VSV Vectored Vaccines for Immunization Against HIV
Yazar:: Udem Steve
Baskı/Yayın Bilgisi: (2005-12-01)

Suitable Promoter for DNA Vaccination Using a pDNA Ternary Complex
Yazar:: Tomoaki Kurosaki, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

gl $$ \mathfrak{gl} $$ N Higgsed networks
Yazar:: Yegor Zenkevich
Baskı/Yayın Bilgisi: (2021-12-01)